Evaluation of complications from radiation treatment for cervical cancer
Official title: Standard Follow-up Program Cervix Cancer (SFP CERVIX)
Run by University Medical Center Groningen · NCT02733289 · Data updated 2026-11-12
This study is looking at the side effects and recovery experiences of women with cervical cancer who are receiving radiation treatment to see how it affects them over time.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Women only |
| Enrollment | 10000 (estimated) |
| Sponsor | University Medical Center Groningen Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Groningen) |
| Status | Recruiting |
| Started | June 2015 |
| Main results expected | December 2040 |
| Study ends | December 2040 |
| Registry record updated | February 28, 2024 |
| Trial ID | NCT02733289 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are cervical cancer patients who are receiving curative radiation treatment.
✕Probably not a fit
Patients undergoing non-curative treatment or those receiving part of their treatment at another hospital may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather standard follow-up data on complications experienced by patients undergoing curative radiation treatment for cervical cancer. It involves evaluating the outcomes and side effects of the treatment over time. The study will include all cervical cancer patients treated with curative intent at the University Medical Center Groningen, focusing on their recovery and any complications that arise post-treatment.
Why it matters
Potential benefit: If successful, this study could improve the understanding of radiation-related complications, leading to better management and care for cervical cancer patients.
How similar studies have gone: While this study focuses on standard follow-up, similar observational studies have shown success in understanding treatment complications in other cancer types.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Every cervical cancer patient with curative intent for radiotherapy, treated at our department Exclusion Criteria: * Non-curative treatment * Part of the treatment is given in another hospital
Where it's running
-
University Medical Center Groningen
Groningen, Netherlands Recruiting
Study contacts
- Principal investigator: Jannet Beukema — Principal Investigator
- Study coordinator: Jannet Beukema
- Email: j.c.beukema@umcg.nl
- Phone: +31503610025
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.